These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 19439761)
1. Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux. Vrins CL; van der Velde AE; van den Oever K; Levels JH; Huet S; Oude Elferink RP; Kuipers F; Groen AK J Lipid Res; 2009 Oct; 50(10):2046-54. PubMed ID: 19439761 [TBL] [Abstract][Full Text] [Related]
2. Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1. van der Veen JN; Kruit JK; Havinga R; Baller JF; Chimini G; Lestavel S; Staels B; Groot PH; Groen AK; Kuipers F J Lipid Res; 2005 Mar; 46(3):526-34. PubMed ID: 15604518 [TBL] [Abstract][Full Text] [Related]
3. Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterol. Briand F; Naik SU; Fuki I; Millar JS; Macphee C; Walker M; Billheimer J; Rothblat G; Rader DJ Clin Transl Sci; 2009 Apr; 2(2):127-33. PubMed ID: 20169010 [TBL] [Abstract][Full Text] [Related]
4. Intestinal Farnesoid X Receptor Controls Transintestinal Cholesterol Excretion in Mice. de Boer JF; Schonewille M; Boesjes M; Wolters H; Bloks VW; Bos T; van Dijk TH; Jurdzinski A; Boverhof R; Wolters JC; Kuivenhoven JA; van Deursen JM; Oude Elferink RPJ; Moschetta A; Kremoser C; Verkade HJ; Kuipers F; Groen AK Gastroenterology; 2017 Apr; 152(5):1126-1138.e6. PubMed ID: 28065787 [TBL] [Abstract][Full Text] [Related]
5. NPC1L1 and ABCG5/8 induction explain synergistic fecal cholesterol excretion in ob/ob mice co-treated with PPAR-α and LXR agonists. Srivastava RAK; Cefalu AB; Srivastava NS; Averna M Mol Cell Biochem; 2020 Oct; 473(1-2):247-262. PubMed ID: 32661772 [TBL] [Abstract][Full Text] [Related]
6. Transintestinal Cholesterol Transport Is Active in Mice and Humans and Controls Ezetimibe-Induced Fecal Neutral Sterol Excretion. Jakulj L; van Dijk TH; de Boer JF; Kootte RS; Schonewille M; Paalvast Y; Boer T; Bloks VW; Boverhof R; Nieuwdorp M; Beuers UH; Stroes ES; Groen AK Cell Metab; 2016 Dec; 24(6):783-794. PubMed ID: 27818259 [TBL] [Abstract][Full Text] [Related]
7. Regulation of the expression of cholesterol transporters by lipid-lowering drugs ezetimibe and pemafibrate in rat liver and intestine. Tanaka Y; Kamisako T Biochim Biophys Acta Mol Basis Dis; 2021 Nov; 1867(11):166215. PubMed ID: 34265370 [TBL] [Abstract][Full Text] [Related]
8. Fisetin, a dietary flavonoid, promotes transintestinal cholesterol excretion through the activation of PPARδ. Guo Y; Liu B; Geng Y; Chen K; Li J; Yin X; Zhang S Food Res Int; 2024 Jan; 175():113783. PubMed ID: 38129008 [TBL] [Abstract][Full Text] [Related]
9. Intestinal SR-BI does not impact cholesterol absorption or transintestinal cholesterol efflux in mice. Bura KS; Lord C; Marshall S; McDaniel A; Thomas G; Warrier M; Zhang J; Davis MA; Sawyer JK; Shah R; Wilson MD; Dikkers A; Tietge UJF; Collet X; Rudel LL; Temel RE; Brown JM J Lipid Res; 2013 Jun; 54(6):1567-1577. PubMed ID: 23564696 [TBL] [Abstract][Full Text] [Related]
10. Liver-specific induction of Abcg5 and Abcg8 stimulates reverse cholesterol transport in response to ezetimibe treatment. Altemus JB; Patel SB; Sehayek E Metabolism; 2014 Oct; 63(10):1334-41. PubMed ID: 25060694 [TBL] [Abstract][Full Text] [Related]
11. Regulation of intestinal NPC1L1 expression by dietary fish oil and docosahexaenoic acid. Mathur SN; Watt KR; Field FJ J Lipid Res; 2007 Feb; 48(2):395-404. PubMed ID: 17114806 [TBL] [Abstract][Full Text] [Related]
12. Induction of fecal cholesterol excretion is not effective for the treatment of hyperbilirubinemia in Gunn rats. Blankestijn M; van de Peppel IP; Dvorak A; Capkova N; Vitek L; Jonker JW; Verkade HJ Pediatr Res; 2021 Feb; 89(3):510-517. PubMed ID: 32357361 [TBL] [Abstract][Full Text] [Related]
14. From blood to gut: direct secretion of cholesterol via transintestinal cholesterol efflux. Vrins CL World J Gastroenterol; 2010 Dec; 16(47):5953-7. PubMed ID: 21157971 [TBL] [Abstract][Full Text] [Related]
15. The combination of ezetimibe and ursodiol promotes fecal sterol excretion and reveals a G5G8-independent pathway for cholesterol elimination. Wang Y; Liu X; Pijut SS; Li J; Horn J; Bradford EM; Leggas M; Barrett TA; Graf GA J Lipid Res; 2015 Apr; 56(4):810-20. PubMed ID: 25635125 [TBL] [Abstract][Full Text] [Related]
16. Transintestinal cholesterol efflux. van der Velde AE; Brufau G; Groen AK Curr Opin Lipidol; 2010 Jun; 21(3):167-71. PubMed ID: 20410820 [TBL] [Abstract][Full Text] [Related]
17. Efficient reabsorption of transintestinally excreted cholesterol is a strong determinant for cholesterol disposal in mice. van de Peppel IP; Bertolini A; van Dijk TH; Groen AK; Jonker JW; Verkade HJ J Lipid Res; 2019 Sep; 60(9):1562-1572. PubMed ID: 31324653 [TBL] [Abstract][Full Text] [Related]
19. Transintestinal cholesterol excretion in health and disease. Garçon D; Berger JM; Cariou B; Le May C Curr Atheroscler Rep; 2022 Mar; 24(3):153-160. PubMed ID: 35138569 [TBL] [Abstract][Full Text] [Related]
20. Ezetimibe Promotes Brush Border Membrane-to-Lumen Cholesterol Efflux in the Small Intestine. Nakano T; Inoue I; Takenaka Y; Ono H; Katayama S; Awata T; Murakoshi T PLoS One; 2016; 11(3):e0152207. PubMed ID: 27023132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]